- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Gland Pharma Limited — Updates, 03-11-2025: Press Release
03-11-2025 | 04:51 pm
03-11-2025 | 04:51 pm
Gland Pharma saw strong Q2 results with revenue up 6% to ₹1,486.9 Cr and PAT up 12% to ₹183.7 Cr. US sales grew 10%, Europe 16%, and Cenexi revenue rose 21%. The company launched seven new US molecules and is significantly expanding GLP-1 capacity.
No comments yet. Be the first to comment!